Clinical Research in Cardiology

Papers
(The H4-Index of Clinical Research in Cardiology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Correction to: An unintentional complication during an intentional procedure—Sinus of Valsalva laceration during BASILICA63
Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography50
Association of daily physical activity with pulmonary artery pressure in HFpEF and HFmrEF NYHA class III patients: a pilot trial—feasibility and first results50
Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial50
Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry49
Ventilation strategies in cardiogenic shock: insights from the FRENSHOCK observational registry48
Changes in numbers needed to treat and hospital care expenditures of optimized indications for primary prevention implantable cardioverter defibrillators: a scenario analysis39
Simultaneous transcatheter valve-in-valve replacement of severely degenerated bioprosthetic aortic and mitral prostheses35
Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial32
Lessons learned from catheter ablation of ventricular arrhythmias in patients with a fully magnetically levitated left ventricular assist device32
Heart failure burden and care among cardiology inpatients: insights from the Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study31
Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy31
Drug overdose and the risk of cardiovascular diseases: a nested case–control study28
Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial27
10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic27
Correlation of greyzone fibrosis compared to troponin T and late gadolinium enhancement with survival and ejection fraction in patients after acute myocardial infarction26
Biventricular impella (BiPella) utilization in fulminant COVID-19 myopericarditis-mediated cardiogenic shock during pregnancy25
Prognostic utility of a multi-biomarker panel in patients with suspected myocardial infarction25
Protective effect of vaccination on the risk of cardiovascular disease after SARS-CoV-2 infection24
Venting during venoarterial extracorporeal membrane oxygenation24
Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort24
Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registry24
Outcome of patients with idiopathic ventricular fibrillation and correlation with ECG markers of early repolarization23
Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials23
Heterogeneity of outcomes within diabetic patients with atrial fibrillation on edoxaban: a sub-analysis from the ETNA-AF Europe registry23
0.073210954666138